Alcon AG (ALC)
$85.74 -$0.81 (-0.94%) 4:40 PM 12/12/24
NYSE | $USD | Medical Instruments & SuppliesStock Data
-
Market Cap
$43.09B -
Day's Range
$85.73 - $86.34 -
Volume
741,023 -
52 Week Low / High
$71.81 - $101.10 -
PE Ratio
37.08x -
PEG Ratio
3.10 -
Dividend Frequency
annual
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 16
- Strong Buy
- 7
- Buy
- 4
- Hold
- 1
- Sell
- 0
- Strong Sell
- $93.30
- Target Price
Company News
-
Alcon Innovations on Display at AAO 2024 Demonstrate Efficiency and Performance — Oct 15th, 2024
Attendees can experience a first look at Voyager DSLT, Alcon’s new first-line laser therapy for glaucoma patients Alcon introduces new handheld gas delivery systems, UNIFEYE and UNIPEXY, optimizing convenience and accuracy for retina surgeons In addition, Alcon presents pivotal data for ...
-
Alcon Innovations on Display at AAO 2024 Demonstrate Efficiency and Performance — Oct 15th, 2024
Attendees can experience a first look at Voyager DSLT, Alcon’s new first-line laser therapy for glaucoma patients Alcon introduces new handheld gas delivery systems, UNIFEYE and UNIPEXY, optimizing convenience and accuracy for retina surgeons In addition, Alcon presents pivotal data for ...
-
Alcon Innovations on Display at AAO 2024 Demonstrate Efficiency and Performance — Oct 15th, 2024
Attendees can experience a first look at Voyager DSLT, Alcon’s new first-line laser therapy for glaucoma patients Alcon introduces new handheld gas delivery systems, UNIFEYE and UNIPEXY, optimizing convenience and accuracy for retina surgeons In addition, Alcon presents pivotal data for ...
-
Alcon Innovations on Display at AAO 2024 Demonstrate Efficiency and Performance — Oct 15th, 2024
Attendees can experience a first look at Voyager DSLT, Alcon’s new first-line laser therapy for glaucoma patients Alcon introduces new handheld gas delivery systems, UNIFEYE and UNIPEXY, optimizing convenience and accuracy for retina surgeons In addition, Alcon presents pivotal data for ...
-
Alcon Innovations on Display at AAO 2024 Demonstrate Efficiency and Performance — Oct 15th, 2024
Attendees can experience a first look at Voyager DSLT, Alcon’s new first-line laser therapy for glaucoma patients Alcon introduces new handheld gas delivery systems, UNIFEYE and UNIPEXY, optimizing convenience and accuracy for retina surgeons In addition, Alcon presents pivotal data for ...
-
Alcon Innovations on Display at AAO 2024 Demonstrate Efficiency and Performance — Oct 15th, 2024
Attendees can experience a first look at Voyager DSLT, Alcon’s new first-line laser therapy for glaucoma patients Alcon introduces new handheld gas delivery systems, UNIFEYE and UNIPEXY, optimizing convenience and accuracy for retina surgeons In addition, Alcon presents pivotal data for ...
-
Reasons to Retain Alcon Stock in Your Portfolio for Now — Sep 24th, 2024
Alcon Inc.’s ALC growth is driven by its robust Surgical business. The performance of the Vision Care arm also appears encouraging. However, concerns remain about the macroeconomic headwinds, which may strain the company’s margin performance. Competitive disadvantages also add to the ...
-
Alcon Innovations on Display at AAO 2024 Demonstrate Efficiency and Performance — Oct 15th, 2024
Attendees can experience a first look at Voyager DSLT, Alcon’s new first-line laser therapy for glaucoma patients Alcon introduces new handheld gas delivery systems, UNIFEYE and UNIPEXY, optimizing convenience and accuracy for retina surgeons In addition, Alcon presents pivotal data for ...
-
Alcon Innovations on Display at AAO 2024 Demonstrate Efficiency and Performance — Oct 15th, 2024
Attendees can experience a first look at Voyager DSLT, Alcon’s new first-line laser therapy for glaucoma patients Alcon introduces new handheld gas delivery systems, UNIFEYE and UNIPEXY, optimizing convenience and accuracy for retina surgeons In addition, Alcon presents pivotal data for ...
Portfolio
Comprised of 1 portfolios